Literature DB >> 9516190

Polycythemic responses to hypoxia: molecular and genetic mechanisms of chronic mountain sickness.

L C Ou1, S Salceda, S J Schuster, L M Dunnack, T Brink-Johnsen, J Chen, J C Leiter.   

Abstract

We examined erythropoietin (EPO) gene expression and EPO production during hypoxia in two Sprague-Dawley rat strains with divergent polycythemic responses to hypoxia. Hilltop (H) rats develop severe polycythemia, severe hypoxemia, and pulmonary artery hypertension. The H rats often die from a syndrome indistinguishable from chronic mountain sickness (CMS) in humans. Madison (M) rats develop polycythemia and pulmonary artery hypertension that is modest and suffer no excess mortality. We tested the hypothesis that these rat strains have different stimulus-response characteristics governing EPO production. Rats of each strain were exposed to hypoxia (0.5 atm, 73 Torr inspired PO2), and renal tissue EPO mRNA and EPO levels, plasma EPO, ventilation, arterial and renal venous blood gases, and indexes of renal function were measured at fixed times during a 30-day hypoxic exposure. During extended hypoxic exposure, H rats had significantly elevated renal EPO mRNA, renal EPO, and plasma EPO levels compared with M rats. Ventilatory responses and indexes of renal function were similar in the strains during the hypoxic exposure. H rats had greater arterial hypoxemia from the onset of hypoxia and more severe renal tissue hypoxemia and greater polycythemia after 14 days of hypoxic exposure. When EPO responses were expressed as functions of renal venous PO2, the two strains appeared to lie on the same dose-response curves, but the responses of H rats were shifted along the curve toward more hypoxic values. We conclude that H rats have significantly greater polycythemia secondary to poorer renal tissue oxygenation, but the stimulus-response characteristics governing EPO gene expression and EPO production do not seem to differ between M and H rats. Finally, the regulation of EPO levels during hypoxia occurs primarily at the transcriptional level.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9516190     DOI: 10.1152/jappl.1998.84.4.1242

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  11 in total

1.  "Living high and training low" can improve sea level performance in endurance athletes.

Authors:  J Stray-Gundersen; B D Levine
Journal:  Br J Sports Med       Date:  1999-06       Impact factor: 13.800

2.  Acute short-term hyperoxia followed by mild hypoxia does not increase EPO production: resolving the "normobaric oxygen paradox".

Authors:  Tadej Debevec; Michail E Keramidas; Barbara Norman; Thomas Gustafsson; Ola Eiken; Igor B Mekjavic
Journal:  Eur J Appl Physiol       Date:  2011-07-07       Impact factor: 3.078

3.  Renal Anemia Model Mouse Established by Transgenic Rescue with an Erythropoietin Gene Lacking Kidney-Specific Regulatory Elements.

Authors:  Ikuo Hirano; Norio Suzuki; Shun Yamazaki; Hiroki Sekine; Naoko Minegishi; Ritsuko Shimizu; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2017-02-01       Impact factor: 4.272

4.  Physiological Genomics of Adaptation to High-Altitude Hypoxia.

Authors:  Jay F Storz; Zachary A Cheviron
Journal:  Annu Rev Anim Biosci       Date:  2020-11-23       Impact factor: 8.923

Review 5.  Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid.

Authors:  Randall L Wilber
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 6.  The effect of altitude on cycling performance: a challenge to traditional concepts.

Authors:  A G Hahn; C J Gore
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

7.  Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha.

Authors:  A Y Yu; L A Shimoda; N V Iyer; D L Huso; X Sun; R McWilliams; T Beaty; J S Sham; C M Wiener; J T Sylvester; G L Semenza
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

8.  Arterial oxygen content is precisely maintained by graded erythrocytotic responses in settings of high/normal serum iron levels, and predicts exercise capacity: an observational study of hypoxaemic patients with pulmonary arteriovenous malformations.

Authors:  Vatshalan Santhirapala; Louisa C Williams; Hannah C Tighe; James E Jackson; Claire L Shovlin
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

9.  The treatment of Uygur medicine Dracocephalum moldavica L on chronic mountain sickness rat model.

Authors:  Dilinuer Maimaitiyiming; Guangmei Hu; Ainiwaer Aikemu; Shi Wen Hui; Xiangyang Zhang
Journal:  Pharmacogn Mag       Date:  2014-10       Impact factor: 1.085

10.  Genetic variants in EPAS1 contribute to adaptation to high-altitude hypoxia in Sherpas.

Authors:  Masayuki Hanaoka; Yunden Droma; Buddha Basnyat; Michiko Ito; Nobumitsu Kobayashi; Yoshihiko Katsuyama; Keishi Kubo; Masao Ota
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.